Solvent molecules occupy defined sites within the crystal lattice and interact with nearby compound molecules, including through hydrogen bonding. These interactions can affect how the surrounding molecules are arranged and how strongly the lattice is maintained. As a result, the incorporated solvent is a structural feature that may influence the solid form’s behavior during development and storage.
Solvent composition, temperature, and drying conditions are important variables. Changes in solvent composition can alter which crystalline form develops, while temperature may influence formation or transformation. Drying can also change the amount of solvent retained in the lattice. Controlling these conditions helps reduce unintended changes in the solid form during processing.
The amount and organization of incorporated solvent can influence solid-state stability, dissolution, and bioavailability. It may also affect how consistently a drug substance behaves during manufacturing. Because these properties are linked to clinical product performance, researchers evaluate solvent-containing forms rather than treating solvent content as an incidental feature of crystallization.
Processing and storage may alter the solvent content within the lattice, potentially causing a crystal form to transform. Such changes can affect stability, dissolution, and manufacturing consistency. Evaluating the material under relevant drying, processing, and storage conditions helps researchers determine whether the selected form remains reliable throughout the drug-substance lifecycle.
Characterization should determine how the incorporated solvent relates to the crystal form and whether that form remains stable under intended conditions. Researchers also assess consequences for dissolution, bioavailability, and manufacturability. These evaluations support comparison of candidate solid forms and help identify a drug substance that can maintain consistent performance.
They become especially important when crystallization, drying, processing, or storage may change incorporated solvent content. Researchers use this information to judge solid-state stability and manufacturing reliability alongside dissolution and bioavailability. The goal is to select a form whose properties remain sufficiently consistent for clinical development and controlled pharmaceutical production.